Aripiprazole and Ketoconazole Topical: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Aripiprazole
Ketoconazole Topical
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased ARIPiprazole exposure and an increased risk of QT interval prolongation
Interaction Deep Dive
Coadministration of ketoconazole with ARIPiprazole is contraindicated1. Reduce the usual ARIPiprazole dose to 50% for patients on CYP3A inhibitors and to 25% for patients on dual CYP3A/CYP2D6 inhibitors 2. If CYP3A inhibitor use exceeds 14 days, reduce ARIPiprazole IM dose 400 mg to 300 mg, 300 mg to 200 mg. With dual CYP3A/CYP2D6 inhibitor use reduce ARIPiprazole IM dose 400 mg to 200 mg, 300 mg to 160 mg. If coadministered for less than 14 days, no dosage adjustment is recommended. Increase ARIPiprazole dose once the inhibitor is discontinued 3. Avoid ARIPiprazole ER 2-months injection use in patients on both strong dual CYP3A/CYP2D6 inhibitors for over 14 days. In patients only on strong CYP3A inhibitors, use 720 mg once every 2 months 4. If coadministered, reduce Aristada(R) to the next lower strength, no dose change for 441 mg monthly if tolerated 5.
Why it happens (mechanism)
Inhibition of CYP3A-mediated metabolism of ARIPiprazole; additive QT interval prolongation
Literature reports
1 report — tap to read
Common questions
Can I take Aripiprazole and Ketoconazole Topical together?
Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Always confirm with your pharmacist or prescriber before making any change.
How serious is the Aripiprazole and Ketoconazole Topical interaction?
It is rated contraindicated. These should generally not be used together.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Questions for your pharmacist
- Does my dose of Aripiprazole or Ketoconazole Topical need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (5)
- Product Information: Ketoconazole oral tablet, ketoconazole oral tablet. Taro Pharmaceuticals U.S.A. Inc. (per DailyMed), Hawthorne, NY, 2024. DailyMed
- Product Information: ABILIFY(R) oral tablets, oral solution, intramuscular injection, aripiprazole oral tablets, oral solution, intramuscular injection. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2022. DailyMed
- Product Information: ABILIFY MAINTENA(R) intramuscular extended-release injection, aripiprazole intramuscular extended-release injection. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2020.
- Product Information: ABILIFY ASIMTUFII(R) intramuscular extended-release suspension, aripiprazole intramuscular extended-release suspension. Otsuka America Pharmaceutical Inc (per FDA), Rockville, MD, 2023.
- Product Information: ARISTADA(R) intramuscular extended-release injection, aripiprazole lauroxil intramuscular extended-release injection. Alkermes Inc (per FDA), Waltham, MA, 2018.
Keep reading about Aripiprazole
Keep reading about Ketoconazole Topical
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist